1
|
Guerado E and Caso E: The physiopathology
of avascular necrosis of the femoral head: An update. Injury.
47(Suppl 6): S16–S26. 2016. View Article : Google Scholar
|
2
|
Youm YS, Lee SY and Lee SH: Apoptosis in
the osteonecrosis of the femoral head. Clin Orthop Surg. 2:250–225.
2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Calder JD, Buttery L, Revell PA, Pearse M
and Polak JM: Apoptosis-a significant cause of bone cell death in
osteonecrosis of the femoral head. J Bone Joint Surg Br.
86:1209–1213. 2004. View Article : Google Scholar : PubMed/NCBI
|
4
|
Assouline-Dayan Y, Chang C, Greenspan A,
Shoenfeld Y and Gershwin ME: Pathogenesis and natural history of
osteonecrosis. Semin Arthritis Rheum. 32:94–124. 2002. View Article : Google Scholar : PubMed/NCBI
|
5
|
Cui Q, Wang GJ, Su CC and Balian G: The
otto aufranc award. Lovastatin prevents steroid induced
adipogenesis and osteonecrosis. Clin Orthop Relat Res. 8–19.
1997.PubMed/NCBI
|
6
|
Wang GJ, Sweet DE, Reger SI and Thompson
RC: Fat-cell changes as a mechanism of avascular necrosis of the
femoral head in cortisone-treated rabbits. J Bone Joint Surg Am.
59:729–35. 1977. View Article : Google Scholar : PubMed/NCBI
|
7
|
Kannu P, O'Rielly DD, Hyland JC and Kokko
LA: Avascular necrosis of the femoral head due to a novel C
propeptide mutation in COL2A1. Am J Med Genet A. 155A:1759–1762.
2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
9
|
Chen SL, Fang WW, Ye F, Liu YH, Qian J,
Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, Lin S and Sun JP: Effect on
left ventricular function of intracoronary transplantation of
autologous bone marrow mesenchymal stem cell in patients with acute
myocardial infarction. Am J Cardiol. 94:92–95. 2004. View Article : Google Scholar : PubMed/NCBI
|
10
|
Wang S, Qu X and Zhao RC: Clinical
applications of mesenchymal stem cells. J Hematol Oncol. 5:192012.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Hare JM, Fishman JE, Gerstenblith G,
DiFede VD, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston
PV, Brinker JA, et al: Comparison of allogeneic vs autologous bone
marrow-derived mesenchymal stem cells delivered by transendocardial
injection in patients with ischemic cardiomyopathy: The POSEIDON
randomized trial. JAMA. 308:2369–2379. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Liang J, Li X, Zhang H, Wang D, Feng X,
Wang H, Hua B, Liu B and Sun L: Allogeneic mesenchymal stem cells
transplantation in patients with refractory RA. Clin Rheumatol.
31:157–161. 2012. View Article : Google Scholar
|
13
|
Zhao D, Cui D, Wang B, Tian F, Guo L, Yang
L, Liu B and Yu X: Treatment of early stage osteonecrosis of the
femoral head with autologous implantation of bone marrow-derived
and cultured mesenchymal stem cells. Bone. 50:325–330. 2012.
View Article : Google Scholar
|
14
|
Guttman M, Amit I, Garber M, French C, Lin
MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Guttman M, Donaghey J, Carey BW, Garber M,
Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, et al:
lincRNAs act in the circuitry controlling pluripotency and
differentiation. Nature. 477:295–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
17
|
Li X, Wu Z, Fu X and Han W: Long noncoding
RNAs: Insights from biological features and functions to diseases.
Med Res Rev. 33:517–553. 2013. View Article : Google Scholar
|
18
|
Lee JT and Bartolomei MS: X-inactivation,
imprinting, and long noncoding RNAs in health and disease. Cell.
152:1308–1323. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wang L, Wang Y, Li Z, Li Z and Yu B:
Differential expression of long noncoding ribonucleic acids during
osteogenic differentiation of human bone marrow mesenchymal stem
cells. Int Orthop. 39:1013–1019. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Jiang Y, Jahagirdar BN, Reinhardt RL,
Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund
T, Blackstad M, et al: Pluripotency of mesenchymal stem cells
derived from adult marrow. Nature. 418. pp. 41–49. 2002, View Article : Google Scholar
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
22
|
Moya-Angeler J, Gianakos AL, Villa JC, Ni
A and Lane JM: Current concepts on osteonecrosis of the femoral
head. World J Orthop. 6:590–601. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Papakostidis C, Tosounidis TH, Jones E and
Giannoudis PV: The role of 'cell therapy' in osteonecrosis of the
femoral head. A systematic review of the literature and
meta-analysis of 7 studies. Acta Orthop. 87:72–78. 2016. View Article : Google Scholar
|
24
|
Pepke W, Kasten P, Beckmann NA, Janicki P
and Egermann M: Core decompression and autologous bone marrow
concentrate for treatment of femoral head osteonecrosis: A
randomized prospective study. Orthop Rev (Pavia). 8:61622016.
View Article : Google Scholar
|
25
|
Mukisi MM, Bashoun K and Burny F:
Sickle-cell hip necrosis and intraosseous pressure. Orthop
Traumatol Surg Res. 95:134–138. 2009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Kumar MN, Belehalli P and Ramachandra P:
PET/CT study of temporal variations in blood flow to the femoral
head following low-energy fracture of the femoral neck.
Orthopedics. 37:e563–e570. 2014. View Article : Google Scholar : PubMed/NCBI
|
27
|
Zeng X, Zhan K, Zhang L, Zeng D, Yu W,
Zhang X, Zhao M, Lai Z and Chen R: The impact of high total
cholesterol and high low-density lipoprotein on avascular necrosis
of the femoral head in low-energy femoral neck fractures. J Orthop
Surg Res. 12:302017. View Article : Google Scholar : PubMed/NCBI
|
28
|
Jones LC and Hungerford DS: The
pathogenesis of osteonecrosis. Instr Course Lect. 56:179–196.
2007.PubMed/NCBI
|
29
|
Kerachian MA, Séguin C and Harvey EJ:
Glucocorticoids in osteonecrosis of the femoral head: A new
understanding of the mechanisms of action. J Steroid Biochem Mol
Biol. 114:121–128. 2009. View Article : Google Scholar : PubMed/NCBI
|
30
|
Jilka RL, Noble B and Weinstein RS:
Osteocyte apoptosis. Bone. 54:264–271. 2013. View Article : Google Scholar :
|
31
|
Wu Z, Ji C, Li H, Qiu G, Gao C and Weng X:
Elevated level of membrane microparticles in the disease of
steroid-induced vascular osteonecrosis. J Craniofac Surg.
24:1252–1256. 2013. View Article : Google Scholar : PubMed/NCBI
|
32
|
Zheng L, Wang W, Ni J, Li Z and Xiao T:
The association of eNOS gene polymorphism with avascular necrosis
of femoral head. PLoS One. 9:e875832014. View Article : Google Scholar : PubMed/NCBI
|
33
|
Tian L, Wen Q, Dang X, You W, Fan L and
Wang K: Immune response associated with Toll-like receptor 4
signaling pathway leads to steroid-induced femoral head
osteonecrosis. BMC Musculoskelet Disord. 15:182014. View Article : Google Scholar : PubMed/NCBI
|
34
|
Lee JS, Lee JS, Roh HL, Kim CH, Jung JS
and Suh KT: Alterations in the differentiation ability of
mesenchymal stem cells in patients with nontraumatic osteonecrosis
of the femoral head: Comparative analysis according to the risk
factor. J Orthop Res. 24:604–609. 2006. View Article : Google Scholar : PubMed/NCBI
|
35
|
Huang S, Wang S, Bian C, Yang Z, Zhou H,
Zeng Y, Li H, Han Q and Zhao RC: Upregulation of miR-22 promotes
osteogenic differentiation and inhibits adipogenic differentiation
of human adipose tissue-derived mesenchymal stem cells by
repressing HDAC6 protein expression. Stem Cells Dev. 21:2531–2540.
2012. View Article : Google Scholar : PubMed/NCBI
|
36
|
Zeng Y, Qu X, Li H, Huang S, Wang S, Xu Q,
Lin R, Han Q, Li J and Zhao RC: MicroRNA-100 regulates osteogenic
differentiation of human adipose-derived mesenchymal stem cells by
targeting BMPR2. FEBS Lett. 586:2375–2381. 2012. View Article : Google Scholar : PubMed/NCBI
|
37
|
Wang Q, Yang Q, Chen G, Du Z, Ren M, Wang
A, Zhao H, Li Z, Zhang G and Song Y: LncRNA expression profiling of
BMSCs in osteonecrosis of the femoral head associated with
increased adipogenic and decreased osteogenic differentiation. Sci
Rep. 8:91272018. View Article : Google Scholar : PubMed/NCBI
|
38
|
Wu D, Xu Y, Zou Y, Zuo Q, Huang S, Wang S,
Lu X, He X, Wang J, Wang T and Sun L: Long noncoding RNA 00473 is
involved in preeclampsia by LSD1 binding-regulated TFPI2
transcription in trophoblast cells. Mol Ther Nucleic Acids.
12:381–392. 2018. View Article : Google Scholar : PubMed/NCBI
|
39
|
Wang L, Zhang X, Sheng L, Qiu C and Luo R:
LINC00473 promotes the Taxol resistance via miR-15a in colorectal
cancer. Biosci Rep. 38:BSR201807902018. View Article : Google Scholar : PubMed/NCBI
|
40
|
Zhang W and Song Y: LINC00473 predicts
poor prognosis and regulates cell migration and invasion in gastric
cancer. Biomed Pharmacother. 107:1–6. 2018. View Article : Google Scholar : PubMed/NCBI
|
41
|
Wang D, Li J, Cai F, Xu Z, Li L, Zhu H,
Liu W, Xu Q, Cao J, Sun J and Tang J: Overexpression of MAPT-AS1 is
associated with better patient survival in breast cancer. Biochem
Cell Biol. 97:158–164. 2019. View Article : Google Scholar
|
42
|
Pan Y, Pan Y, Cheng Y, Yang F, Yao Z and
Wang O: Knockdown of LncRNA MAPT-AS1 inhibites proliferation and
migration and sensitizes cancer cells to paclitaxel by regulating
MAPT expression in ER-negative breast cancers. Cell Biosci.
8:72018. View Article : Google Scholar : PubMed/NCBI
|
43
|
Coupland KG, Kim WS, Halliday GM, Hallupp
M, Dobson-Stone C and Kwok JB: Role of the long non-coding RNA
MAPT-AS1 in regulation of microtubule associated protein Tau (MAPT)
expression in Parkinson's disease. PLoS One. 11:e01579242016.
View Article : Google Scholar : PubMed/NCBI
|